Answers are grounded in this paper and cite their sources.
This study aimed to investigate the regulatory mechanism of the E3 ubiquitin ligase WW domain containing E3 ubiquitin protein ligase 1 (WWP1) in acute pancreatitis (AP). Using an L-arginine (L-Arg)-induced AP mouse model and primary mouse pancreatic acinar cell model, combined with GEO dataset analysis, we found that WWP1 expression was significantly downregulated in AP, while overexpression of WWP1 alleviated acinar cell injury, inhibited ferroptosis, and suppressed inflammatory responses. Mechanistic studies revealed that WWP1, as an E3 ubiquitin ligase, directly binds to mitogen-activated protein kinase 14 (MAPK14) and promotes its proteasomal degradation; downregulation of WWP1 under AP conditions led to increased stability of MAPK14 protein. Further investigation demonstrated that the m 6 A demethylase AlkB homolog 5 (ALKBH5) was aberrantly upregulated in AP and accelerated WWP1 mRNA degradation in association with the reduction of its overall m 6 A modification level, thereby suppressing WWP1 expression at the epitranscriptional level. Knockdown of ALKBH5 restored WWP1 expression, inhibited MAPK14 activation and ferroptosis, while overexpression of MAPK14 reversed this protective effect. In vivo overexpression of WWP1 effectively attenuated pancreatic pathological damage in AP mice. This study elucidates for the first time the core role of the ALKBH5-WWP1-MAPK14 signaling axis in AP: upregulation of ALKBH5 under AP conditions suppresses WWP1 expression via m 6 A demethylation, relieving its ubiquitin-mediated degradation of MAPK14, leading to aberrant accumulation of MAPK14 and driving acinar cell ferroptosis, thereby providing a new strategy for targeted therapy of AP.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: